Back to Journals » Patient Preference and Adherence » Volume 1

Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia

Authors Hong Liu-Seifert, David H Adams, Haya Ascher-Svanum, Douglas E Faries, Bruce J Kinon

Published 20 December 2007 Volume 2007:1 Pages 9—17

Hong Liu-Seifert, David H Adams, Haya Ascher-Svanum, Douglas E Faries, Bruce J Kinon

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA

Objective: The objective of this study was to examine the relationship between patient beliefs about medication use and their likelihood of discontinuing treatment prematurely. Associations of patient beliefs about medication with clinical psychopathology and their life satisfaction were also assessed.

Methods: This post-hoc analysis used data from a randomized, open label, 1-year trial of antipsychotics in the treatment of patients with schizophrenia or schizoaffective disorders (N = 664). Medication management including dosage adjustment and medication switching was at doctors’ discretion, reflecting naturalistic treatment in usual clinical care settings. Early treatment discontinuation was defined as all-cause study drop out. Patient-reported beliefs about medication were assessed by Rating of Medication Influences (ROMI), degree of clinical psychopathology was measured by Positive and Negative Syndrome Scale (PANSS), and patient quality of life was measured by Lehman Quality of Life Interview (LQLI).

Results: Patient perception of medication benefit was the only strong predictor of treatment duration among the 5 underlying dimensions of medication influence. Higher level of perceived beneficial effect of medication was associated with reduced risk of early treatment discontinuation (Hazard ratio = 0.56, 95% Confidence Interval [0.40, 0.79], p = 0.001). Patients with greater beliefs in the beneficial effect of treatment also had better clinical psychopathology outcome and were more satisfied with their quality of life and well-being.

Conclusion: Understanding the predictors of early treatment discontinuation in the care of schizophrenia patients is important for the development of interventions to improve treatment outcome. Current findings suggest that patient perception of beneficial effect of medication may be a critical factor in achieving treatment persistence and a satisfactory treatment outcome.

Keywords: adherence, compliance, antipsychotic, schizophrenia, patient attitude

Download Article [PDF] 

Readers of this article also read:

Ventilatory requirements of quadriceps resistance training in people with COPD and healthy controls

Houchen-Wolloff L, Sandland CJ, Harrison SL, Menon MK, Morgan MD, Steiner MC, Singh SJ

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:589-595

Published Date: 5 June 2014

Effect of year of study on stress levels in male undergraduate dental students

Alzahem AM, Van der Molen HT, De Boer BJ

Advances in Medical Education and Practice 2013, 4:217-222

Published Date: 18 October 2013

COPD management: role of symptom assessment in routine clinical practice

van der Molen T, Miravitlles M, Kocks JWH

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:461-471

Published Date: 14 October 2013

Effectiveness and medication acceptance of olanzapine disintegrating tablets compared to standard olanzapine tablets in acutely treated psychiatric patients

Jörg Czekalla, Thomas Wagner, Alexander Schacht, Michael Kluge, Bruce Kinon

Patient Preference and Adherence 2007, 1:19-27

Published Date: 20 December 2007

Drug use and barriers to and facilitators of drug treatment for homeless youth

Adeline Nyamathi, Angela Hudson, Malaika Mutere, Ashley Christiani, Jeff Sweat, Kamala Nyamathi, Theresa Broms

Patient Preference and Adherence 2007, 1:1-8

Published Date: 24 October 2007